Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mucocutaneous leishmaniasis: a clinicopathologic classification

O P Sangueza1, J M Sangueza, M J Stiller

  • 1Ronald O. Perelman Department of Dermatology, New York University Medical School, New York.

Journal of the American Academy of Dermatology
|June 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dermatomyositis panniculitis: a clinicopathological and immunohistochemical study of 18 cases.

Journal of the European Academy of Dermatology and Venereology : JEADV·2018
Same author

Evidence- and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis - International League of Dermatological Societies in cooperation with the European Dermatology Forum - Short version.

Journal of the European Academy of Dermatology and Venereology : JEADV·2015
Same author

[Advances in molecular biology and their application in the diagnosis and treatment of melanoma].

Actas dermo-sifiliograficas·2010
Same author

Definition of the features of acquired elastotic hemangioma reporting the clinical and histopathological characteristics of 14 patients.

Journal of cutaneous pathology·2009
Same author

Anetodermic mycosis fungoides: a new clinicopathological variant of mycosis fungoides.

The British journal of dermatology·2007
Same author

Axillary granular parakeratosis.

International journal of dermatology·2001

A new staging system for mucocutaneous leishmaniasis, a parasitic disease, was developed using clinical and immunologic criteria. This system aids in evaluating patient prognosis and guiding treatment decisions for this South American endemic infection.

Area of Science:

  • Parasitology
  • Infectious Diseases
  • Clinical Medicine

Background:

  • Leishmaniasis is a chronic parasitic disease transmitted by sandflies, impacting millions globally.
  • Mucocutaneous leishmaniasis, caused by Leishmania brasiliensis, is prevalent in South America.

Purpose of the Study:

  • To establish a comprehensive staging system for mucocutaneous leishmaniasis.
  • The system integrates clinical, histopathologic, epidemiologic, and immunologic data.

Main Methods:

  • Evaluation of 75 Bolivian patients with mucocutaneous leishmaniasis.
  • Methods included patient history, physical examination, biopsy analysis (cutaneous, mucosal, bone marrow), and immunologic assessment.

Main Results:

Related Experiment Videos

  • Mucocutaneous leishmaniasis progresses through three distinct clinical stages: primary (cutaneous), cicatricial, and secondary (mucocutaneous).
  • The primary stage includes lymphoplasmocytic, tuberculoid, and diffuse cutaneous phases.
  • The secondary stage encompasses edematous, granulomatous proliferative, and granulomatous necrotizing phases.

    • Conclusions:

    • A standardized staging system improves the evaluation of mucocutaneous leishmaniasis patients.
    • Accurate staging enhances prognosis determination and treatment planning for this disease.